Blanver extends range of expertise and will provide input for bone reconstruction.< span id = "more-11676" >
Blanver FarmoquÃmica opened the range. Traditionally, the company provides inputs for the food and pharmaceutical industries, and, now, will manufacture the synthetic hydroxyapatite, a type of calcium phosphate used in large scale in the areas dental, orthopedic, cosmetic and pharmaceutical industries. Dentists use the mineral to bone reconstitution after restoration and implants. In orthopedics, the product can be used as coating of metallic prostheses to accelerate the connection between living tissue and material deployed.
“Our greatest advantage is that we offer a hidroxiapatia nanoestruturada, which has greater surface contact and therefore is more quickly absorbed by the body and the bone regenerates in less time,” explains David Frangioni, CEO of Blanver,
the
component, which has no competitors in Brazil, is already at the stage of manufacture and will be marketed from the first half of 2013 in the country and abroad, especially Europe and the United States. Hydroxyapatite is sold by the pound and the average cost is $ 240. In a dental implant, for example, are used approximately five grams product.
Blanver is one of the three largest producers of excipients in the world and has average annual revenue of $ 200 million. Today, exports account for 40% of the turnover of the company also outsources production stages of medicines and is responsible for manufacturing and distribution to the federal Government of Tenofovir, medicine that integrates the antiaids cocktail and is also used in the treatment of hepatitis b.
. blanver.br
